If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> JANUARY 2013<br /> Pathways<br /> THE CLINICAL TRIALS NETWORK NEWSLETTER<br /> Table of<br /> Contents<br /> 2 JSNM & SNMMI<br /> Collaboration<br /> CTN at a Glance<br /> 3 Biomarker Spotlight:<br /> F-18-Florbetapir<br /> 4 Japanese Symposium<br /> PET Image<br /> Reconstruction Grant<br /> 5 2013 MWM Preview<br /> CTN Webinars<br /> DoD Prostate Cancer<br /> Imaging Grant<br /> DIA 2012 Annual<br /> Meeting<br /> 6 Tech Talk: Strength in<br /> Numbers<br /> PK and Biodistribution<br /> Sampling<br /> 7 Sharing IND Information<br /> Tech Tip<br /> 8 Abstract Accepted for<br /> DIA 2013<br /> Save the Date<br /> An investigational new drug<br /> (IND) application is a request<br /> for authorization from the<br /> U.S. Food and Drug Administration (FDA) to<br /> administer an investigational drug to humans<br /> and be exempt from a law that <a title="Jan_for web page 1" href="http://viewer.zmags.com/publication/c8b68af9?page=1"> JANUARY 2013 Pathways </a> <a title="Jan_for web page 2" href="http://viewer.zmags.com/publication/c8b68af9?page=2"> Do You Need an IND? Continued from page 1. These</a> <a title="Jan_for web page 3" href="http://viewer.zmags.com/publication/c8b68af9?page=3"> bIoMaRKER SPOTLIGHT F-18-FLORBETAPIR:THE FIRST AM</a> <a title="Jan_for web page 4" href="http://viewer.zmags.com/publication/c8b68af9?page=4"> In the NEWS CTN and SNMMI Have Strong Presence at</a> <a title="Jan_for web page 5" href="http://viewer.zmags.com/publication/c8b68af9?page=5"> 2013 MWM Preview CTN Collaborates on Two Unique C</a> <a title="Jan_for web page 6" href="http://viewer.zmags.com/publication/c8b68af9?page=6"> Tech Talk: Strength in Numbers Marybeth Devine, C</a> <a title="Jan_for web page 7" href="http://viewer.zmags.com/publication/c8b68af9?page=7"> Special FEATURE INvESTIGaTIoNal NEw DRuG (IND) Su</a> <a title="Jan_for web page 8" href="http://viewer.zmags.com/publication/c8b68af9?page=8"> CTN/CMIIT Joint Session Proposal accepted for DIa</a>